U.S. gets second COVID-19 vaccine


FDA panel endorses second COVID-19 vaccine for US

The U.S. Food and Drug Administration (FDA) on Friday approved for emergency use a second coronavirus vaccine produced by an American biotechnology company, Moderna.

This clears the way for millions of more Americans to be inoculated next week in a country reeling under a second wave of the pandemic.

Moderna’s is the second vaccine to get FDA’s nod, and it came a week after the agency approved the first one produced by Pfizer and its German partner, BioNTech.

Moderna had said its vaccine was found to be over 94 per cent effective in a clinical trial.

FDA’s Commissioner, Stephen Hahn, said with the second approval, the agency had taken a critical step in the fight the virus “that is causing vast numbers of hospitalisations and deaths” in the U.S.

Reacting to the news, Dr Anthony Fauci, the country’s top infectious disease expert, called the availability of the two vaccines “a historic moment.”

“This to me is a triumph of multi-year investment in biomedical…

Source: Vanguard Newspaper